Skip to main content
Eligibility
for people ages 18 years and up
Location
at San Francisco, California and other locations
Dates
study started
estimated completion:

Description

Summary

The clinical characteristics, initial presentation, management, and outcomes of patients hospitalized with new-onset (first diagnosis) heart failure (HF) or decompensation of chronic HF are poorly understood worldwide. REPORT-HF is a global, prospective, and observational HF disease registry designed to characterize patient trajectories longitudinally during and following an index hospitalization for acute HF.

Official Title

International Registry to Assess mEdical Practice With lOngitudinal obseRvation for Treatment of Heart Failure

Keywords

Acute Heart Failure Registry Heart failure Hospitalized Global Morbidity Mortality Quality of life AHF

Eligibility

You can join if…

Open to people ages 18 years and up

Patients at least 18 years old, or older for those countries where the adult age is above 18 years of age, hospitalized with a primary diagnosis of acute heart failure.

You CAN'T join if...

1-Concomitant participation in any/a clinical trial with any investigational treatment(for any sponsor).

  1. Use of investigational drugs within 5 half-lives of enrollment, or until the expected pharmacodynamic effect has returned to baseline, whichever is longer.

Locations

  • Novartis Investigative Site accepting new patients
    San Diego, California, 92103, USA

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Novartis Pharmaceuticals
ID
NCT02595814
Study Type
Observational [Patient Registry]
Last Updated
March 2017